|
|
 |
|
Viewing report
|
|
|
|
Strategic Analysis of the European DNA Microarrays Market
Frost & Sullivan, May 2010, Pages: 61
This research service analyses the DNA microarrays for research and clinical applications in Europe, strategically, by evaluating the various forces that are currently shaping this maturing market. It analyses the revenue potential for the key segments in this market, namely, gene expression and genotyping and forecast the same till 2016. Regional attractiveness and analysis based on competitive forces is performed. Together, the current market strategies of top four vendors are evaluated and measured for its impact on their respective future market share. Finally, recommendations are made to the vendors at a broader level to gain revenue success in the market.
This Frost & Sullivan research service titled Strategic Analysis of the European DNA Microarrays Market provides a detailed analysis of the status and future opportunities for vendors in the European deoxyribonucleic acid (DNA) microarrays market, especially for research applications. In this research, Frost & Sullivan's expert analysts thoroughly examine the following regions: Germany, France, the United Kingdom, Italy, Spain, Scandinavia and Benelux.
This analysis is available through our Drug Discovery & Clinical Diagnostics Growth Partnership Services programme. With continuous access to intelligence and resources from all seven perspectives of the Complex Business Universe, the Growth Partnership Services programme ensures that you and your Growth Team™ are able to maintain a 360 Degree Perspective of the market. This comprehensive, objective information allows your company to mitigate risk, identify new opportunities, and drive effective strategies for growth.
Market Overview
The European DNA Microarrays Market is Poised to Experience Stable Growth despite the Rising Popularity of Next-generation Sequencing Technologies
The increasing adoption of commercial microarray platforms and pre-printed arrays by life sciences researchers is spurring top-line growth in the European DNA microarrays market. Greater availability of content from next-generation sequencing technologies is significantly boosting new gene expression-related studies in Europe. The DNA microarrays market is in the late growth stage with a stable growth expected in the next five to seven years, despite the growing popularity of next-generation sequencing technologies. “Developing new content for arrays, with improved performance, is the key focus area for the vendors in this market,” says the analyst of this research. “Product differentiation at a competitive price will sustain the growth of vendors in this market.” Multiplexing capabilities in the array format have made DNA arrays a popular choice amongst price-sensitive researchers. This increasing adoption of ready-to-use arrays has impelled vendors to enhance the content and performance of these chips, which is a success in the market.
However, life science researchers in Europe are in a dilemma over choosing the appropriate technology for their experiments in next-generation sequencing. As the funding authorities favour sequencing-based projects, researchers are driven to undertake such experiments. “The funding authorities’ preference towards sequencing based projects is encouraging researchers to propose such projects and gain financial support,” explains the analyst. “This could change the researchers’ interest from microarrays to sequencing based research, which will possibly hamper growth in this market.”
Microarray vendors should look to expand their capabilities beyond DNA research applications. Additionally, strategic partnerships with diagnostic manufacturers to explore the clinical aspect will be beneficial in the long term. “Microarray vendors are attempting to strategise their plans in this market based on their key strengths in this field,” concludes the analyst. “With competition mostly restricted to top participants, product and service differentiation will be the key factors distinguishing participants in this market.”
Market Sectors
Expert Frost & Sullivan analysts thoroughly examine the following market sectors in this research:
- Germany
- France
- The United Kingdom
- Italy
- Spain
- Scandinavia
- Benelux
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
Molecular Diagnostics - Technologies, Markets and Companies
European Cardiac Patient Monitoring Solutions Outlook
European Markets for Business Analytics in Healthcare
Overview of the Western European Peripheral Interventional Devices
Next Generation Sequencing: Opportunities, Trends and World Market
Advances in the Use of Biomarkers in Biochip and Microarray Testing: Innovative Technologies, Growth Opportunities and the Future Market Outlook
European Point of Care Testing Market
Molecular Diagnostics Markets
Advanced (3D/4D) Visualisation and Clinical Applications Markets in Europe
European PCR Reagents Market for Research Applications
|
|
|
|
